Of note, upregulation of HEIH also acted as a sponge for miR-98-5p, leading to activation of the PI3K/AKT signaling pathway, which conferred an advantage to sorafenib resistance in HCC [24]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.